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Martijn A. Huynen,4 Jan A.M. Smeitink,2 Lambert P. van den Heuvel,2 and Leo G. Nijtmans2,*
Mitochondrial complex I deﬁciency is the most prevalent and least understood disorder of the oxidative phosphorylation system. The
genetic cause ofmany cases of isolated complex I deﬁciency is unknown because of insufﬁcient understanding of the complex I assembly
process and the factors involved. We performed homozygosity mapping and gene sequencing to identify the genetic defect in ﬁve
complex I-deﬁcient patients from three different families. All patients harbored mutations in the NDUFAF3 (C3ORF60) gene, of which
the pathogenic nature was assessed by NDUFAF3-GFP baculovirus complementation in ﬁbroblasts.We found that NDUFAF3 is a genuine
mitochondrial complex I assembly protein that interacts with complex I subunits. Furthermore, we show that NDUFAF3 tightly interacts
with NDUFAF4 (C6ORF66), a protein previously implicated in complex I deﬁciency. Additional gene conservation analysis links
NDUFAF3 to bacterial-membrane-insertion gene cluster SecF/SecD/YajC and to C8ORF38, also implicated in complex I deﬁciency. These
data not only show that NDUFAF3 mutations cause complex I deﬁciency but also relate different complex I disease genes by the close
cooperation of their encoded proteins during the assembly process.Introduction
Disorders of the oxidative phosphorylation (OXPHOS)
system have an incidence of approximately 1:5000 living
births, frequently resulting in severe multisystem disease
with a consequence of early childhood death.1–3 The
molecular cause is improper function and/or assembly of
one or more of the ﬁve multiprotein enzyme complexes
of the OXPHOS system.
The most prevalent OXPHOS disorder is isolated
complex I deﬁciency (MIM 252010). So far, sequencing
efforts have attributed about half of the cases to mutations
in one of the seven mitochondrial and 38 nuclear genes
that encode the structural components of complex I.
Frequently, these mutations disturb complex I assembly,
an intricate 45-component puzzle.4 At present, we know
that complex I assembly involves the formation of
multiple assembly intermediates, presumably starting
with several highly conserved subunits (NDUFS2,
NDUFS3, and NDUFS7).4–9 This de novo assembly is
most likely accompanied by subunit exchange to maintain
complex I integrity.7 In addition, aided by recent develop-
ments in bioinformatics and genetics, the number of
putative complex I assembly proteins has grown consider-
ably. Five of these have been implicated in complex I
deﬁciency (NDUFAF1, NDUFAF2, C6ORF66, C8ORF38,
and C20ORF7),10–14 and an additional three have been718 The American Journal of Human Genetics 84, 718–727, June 12shown to be required for complex I assembly (Ecsit, AIF,
and Ind1).15–17
Most likely, many more nonstructural proteins required
for proper complex I function, assembly, and stability
await discovery. This is illustrated by the fact that only
half of the cases of isolated complex I deﬁciency can be
genetically explained.1–3 In a recent paper, Pagliarini
and colleagues have used comparative genomics to
predict proteins involved in complex I biology and
disease, ultimately veriﬁed by RNA interference for several
candidates and the discovery of two complex I-deﬁcient
patients that harbor mutations in candidate gene
C8ORF38 (MIM 612392).13 One of the candidate genes
picked up in this study is C3ORF60, hereafter referred to
as NDUFAF3.
Here, we describe ﬁve complex I-deﬁcient patients with
mutations in the NDUFAF3 gene, and we perform
a detailed study of the requirement of the NDUFAF3
protein for complex I assembly. We show cooperation
between NDUFAF3 and previously described chaperone
NDUFAF4 (C6ORF66) and reveal gene-order conservation
with C8ORF38 and genes involved in the Sec membrane-
insertion machinery in bacteria. The discovery of cooper-
ation between proteins encoded by different complex I
disease genes is an important step forward in the under-
standing of the molecular basis of complex I assembly
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Subjects and Methods
Case Reports
Family I consisted of consanguineous parents of Muslim origin
and their ﬁve children. Their second (I-1), third (I-2), and ﬁfth
(I-3) children, two females and onemale, were born at 34–38weeks
of gestation, and their birth weights were 1490–2560 g. The three
newborns presented similarly with severe lactic acidosis (peak
level 27 mM, n < 2.2) at 1–3 days of life, which persisted and
led to their death at three months of age. Throughout their life,
increased muscle tone developed but physical examination was
otherwise normal. Speciﬁcally, the patients followed moving
objects, smiled socially, and had normal brain MRI, EEG, abdom-
inal ultrasound, and echocardiogram results. Treatment with
dichloroacetate, carnitine, thiamine, and CoQ10 did not affect
the course of the disease.
The patient from the second family (II-1) was a male, the ﬁfth
child born to ﬁrst cousins of Arab-Muslim origin. His parents
and four older siblings were healthy. He was born at term and
had a birth weight of 2900 g. At three weeks of age, he became
hypoactive and sucked poorly. Physical examination revealed
macrocephaly (head circumference þ3 SD), a weak cry, wide ante-
rior fontanelle, and axial hypotonia. Generalized tonic move-
ments were intermittently seen, and fundoscopy revealed bilateral
pallor of the optic disc. Plasma lactate was 5.4mM, and CSF lactate
was 6 mM (n < 1.8). The EEG recording showed a burst suppres-
sion pattern. At three months of age, there was no eye contact
and marked axial hypotonia with brisk tendon reﬂexes and
a lack of sucking were observed. Breathing was irregular, and the
patient was mechanically ventilated and fed via a nasogastric
tube until his death at four months of age. Muscle biopsy was per-
formed at two months of age.
The patient from the third family (III-1) was a daughter of unre-
lated parents of Jewish origin. She was admitted at threemonths of
age because of myoclonic seizure disorder. A brain MRI revealed
diffuse brain leukomalacia, and an abdominal ultrasound dis-
closed left hydroureter and hydronephrosis. Skin ﬁbroblasts
showed mitochondrial complex I deﬁciency. She had respiratory
failure and was readmitted to the hospital two more times. She
died at six months of age.
Enzyme Measurements
For enzymatic assays, mitochondria were isolated from muscle
and ﬁbroblasts as described.18,19 Mitochondrial isolation and
measurement of rotenone-sensitive NADH-ubiquinone reductase
activity were performed as previously described.18,19 Complex I
function was assessed by three assays: NADH-ferricyanide reduc-
tase, rotenone-sensitive NADH-ubiquinone reductase, and rote-
none-sensitive NADH-cytochrome c reductase (complexes I and
III). Activities were normalized to citrate synthase, amitochondrial
matrix enzyme20 (patients of families I and II), or to cytochrome c
oxidase (patient III-1).
Homozygosity Mapping and Sequencing
All experiments involving DNA of the patients, their relatives,
healthy controls, and patient cells were approved by the institu-
tional review boards of the participating centers. Homozygosity
mapping of DNA was performed with the Affymetrix Human
Mapping 50K Array Xba240 for patients I-1 and I-2 of family 1
and with the GeneChip Human Mapping 250K Nsp Array for
family 2, as previously described.21 The NDUFAF3 gene was ampli-The Amﬁed from genomic DNA in ﬁve exons by PCR (primer sequences
available upon request). For exon 1, all three alternative spliced
exons were analyzed. Fragments included both DNA sequences
of the individual exons, the splice donor and splice acceptor sites.
The amplimers thus obtained were subjected to DNA sequence
analysis as described by Hoefs et al.22
Modeling
Homology modeling was performed with the use of the NMR
structure of Rpa2829 protein from Rhodopseudomonas palustris as
a template (Protein Data Bank [PDB] ﬁle 2FVT, 30% sequence
identity). The mitochondrial target signal at the N terminus and
the 11 C-terminal residues could not be modeled. A model of
the aligned residues was built with the WHAT IF web server for
modeling and with the WHAT IF and Yasara Twinset for model
optimization and analysis.23 Default parameters were used during
the entire modeling and model-optimization procedures.
Complementation
We obtained the NDUFAF3 isoform A open reading frame (ORF)
sequence (GI:41327780, without stop codon) ﬂanked by Gateway
ATTB sites (Invitrogen) by PCR and cloned this into pDONR201 by
using the Gateway BP Clonase II enzyme mix (Invitrogen) to
generate the pEntry vectors. GFP-tagged COX8 leader was cloned
as described previously.22 These constructs were then used to
make baculovirus and perform complementation as described
previously.22
RNA Interference
For transfection, HeLa cells were plated in 2 ml of Dulbecco’s
modiﬁed Eagle’s medium (DMEM) supplemented with 10% fetal
calf serum (FCS) (without antibiotics) in 6-well plates with a cell
density of 2.0 3 105 cells per well. The next day, cells were trans-
fectedwith siRNA duplex in the presence of oligofectamine (7.5 ml)
(Invitrogen) and opti-MEM (Invitrogen), for a ﬁnal concentration
of 100 nM siRNA in a total volume of 2.4 ml per well. Control was
cyclophilin B (Dharmacon), NDUFAF3 #1 antisense strand: 50-AU
GUAAGUGAAGUCCCUCC dTdT-30, #2 antisense strand: 50-AGG
AAGUUGAAGGUGGCAC dTdT-30; NDUFAF4 #1 antisense strand:
50- UGGAUAGAGACUAAUCUGC dTdT-30, #2 antisense strand:
50-AUCUUUGGAAUCAACAUAC dTdT-30. Cells were incubated
at 37C in a CO2 incubator for 48 hr, after which the cells were
transferred to new wells. After 24 hr, these cells were transfected
for a second time and incubated for 24 hr before further analysis.
Generation of Inducible Cell Lines and Cell Culture
NDUFS3 (GI:4758787), NDUFAF3 (GI:41327780), and NDUFAF4
(GI:215599255) ORF sequences (without stop codon) ﬂanked by
Gateway AttB sites (Invitrogen) were created by PCR, in accor-
dance with the manufacturer’s instruction, and cloned into
pDONR201 with the use of Gateway BP Clonase II enzyme mix
(Invitrogen). Gateway tandem afﬁnity puriﬁcation (TAP) and
green ﬂuorescent protein (GFP) destination vectors are available
in our lab (previously described in5). For inducible NDUFS3-TAP
and -GFP, NDUFAF3-TAP and -GFP, and NDUFAF4-TAP and -GFP
vectors, the pDONR201 vector containing NDUFS3, NDUFAF3,
andNDUFAF4 inserts was recombined with the TAP andGFP desti-
nation vectors via the Gateway LR Clonase II Enzyme Mix (Invi-
trogen). All constructs were transfected into Flp-In T-REx293 cells
(Invitrogen) with SuperFect Transfection Reagent (QIAGEN), in
accordance with the manufacturer’s protocols. HeLa and Humanerican Journal of Human Genetics 84, 718–727, June 12, 2009 719
Embryonic Kidney (HEK) 293 cells were cultured in DMEM (Bio-
whitaker) supplemented with 10% fetal calf serum (v/v) and 1%
penicillin and streptomycin (v/v) (GIBCO). The inducible cell
lines were treated with 1 mg/ml doxycycline (Sigma Aldrich) for
24 hr for expression of the transgene. For the chloramphenicol-
inhibition experiment, a ﬁnal concentration of 50 mg/ml of chlor-
amphenicol (Sigma Aldrich) was added to the culture medium for
3 days. On the ﬁnal day, 1 mg/ml doxycycline was added for 24 hr
for induction of the transgenes before cell harvest. Patient skin
ﬁbroblasts were cultured in medium 199 supplemented with
10% fetal calf serum, bicarbonate, and antibiotics. The cells were
cultured until conﬂuency.
Localization Studies
For confocal imaging, HEK293 cells expressing inducible
NDUFAF3-GFP were cultured in a Wilco dish (Intracel, Royston,
UK), washed with phosphate-buffered saline (PBS), and incubated
with 1 mMMitotracker Red (Invitrogen) for 15min andwith 10 mM
Hoechst 3342 (Invitrogen) for 30 min, both at 37C. Before
imaging, the culture medium was replaced by a colorless HEPES-
Tris (HT) solution (132 mM NaCl, 4.2 mM KCl, 1 mM CaCl2,
1 mM MgCl2, 5.5 mM D-glucose, and 10 mM HEPES, pH 7.4)
and ﬂuorescence images were taken on a ZEISS LSM510 Meta
confocal microscope (Carl Zeiss). Images were acquired at a rate
of 10 Hz with the use of a 363 oil-immersion objective (N.A.
1.4; Carl Zeiss). Zoom factor 2 and pinhole settings were selected
for the attainment of an optical section thickness of < 1 mm.
Measurements were performed at 20C in the dark. Confocal
images of GFP and MitoTracker Red ﬂuorescence were simulta-
neously collected with the use of an argon laser (laser power 1%)
with a 488 nm dichroic mirror and a 500–530 nm band-pass
barrier ﬁlter in combination with a helium-neon (HeNe) 1 laser
(laser power 43%) with a 543 nm dichroic mirror and a 560 nm
long-pass ﬁlter. With the multitrack setting used, Hoechst ﬂuores-
cence was subsequently imaged with the use of a 405 nm diode
laser (laser power 10%) and a 420–480 band-pass barrier ﬁlter.
Image processing and analysis were performed with Image Pro
Plus 5.1 (Media Cybernetics, Bethesda, MD, USA). For biochemical
fractionation, HEK293 mitochondria were obtained by pottering
as described previously.24 Mitochondria were sonicated on ice
for 10 s at 10% amplitude (Branson Digital Soniﬁer, type
W-250D) in isotonic buffer (0.25 M sucrose, 5 mM Tris-HCL,
0.2 mM EDTA, 1 mM PMSF, protease inhibitor mix [Amersham],
pH 7.5), followed by a 30 min spindown (10.000 g, 4C) to pellet
unbroken mitochondria. The supernatant was submitted to ultra-
centrifugation at 100,000 g for 1 hr. The resulting supernatant
contains the nonmembrane proteins. The pellet was subsequently
resuspended in carbonate buffer (0.1 M Na2CO3, 1 mM PMSF,
Protease Inhibitor Mix [Amersham], pH 11.5) for unfolding of
the membrane structures and incubated for 30 min on ice. After
a second round of ultracentrifugation at 100,000 g for 1 hr, the
supernatant containing peripheral membrane proteins was sepa-
rated from the integral membrane fraction.
Blue-Native- and SDS-PAGE Analysis and CI
In-Gel Activity Assay
One-dimensional 10% sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) and 5%–15% blue-native (BN)-PAGE
was performed as described previously.6,25 Lanes were loaded
with 40 (SDS analysis) or 80 (BN analysis) mg of solubilized mito-
chondrial protein. After electrophoresis, gels were processed720 The American Journal of Human Genetics 84, 718–727, June 12further for in-gel complex I activity assay, in-gel ﬂuorescence
detection, immunoblotting, or two-dimensional 10% SDS-PAGE
as described by Nijtmans et al.25 For blotting, proteins were trans-
ferred to a PROTAN nitrocellulose membrane (Schleicher &
Schuell).
Antibodies and ECL Detection
Afﬁnity-puriﬁed NDUFAF3 antibody was manufactured by Euro-
gentec with the use of two peptides: no. 1, APRRGHRLSPADDELY;
no. 2, RQRGIAVEVQDTPNAC. The NDUFAF4 antibody was kindly
provided by H. Lorberboum-Galski, Jerusalem, Israe¨l. The GFP
antibody was kindly provided by Frank van Kuppeveld, Nijmegen,
The Netherlands. Complex I subunit antibodies were NDUFS3 (In-
vitrogen), ND1 (a gift from Anne Lombes, Paris, France), NDUFS2
(a gift from Brian Robinson,Montreal, Canada), our NDUFA2 anti-
body,8 NDUFA5, NDUFA9, and NDUFS3 (Invitrogen). Other anti-
bodies used were raised against SDHA, Core II, COX5A, ATPase
a (all Invitrogen), cytochrome c, and mtHSP70 (both Abcam).
Secondary antibodies that were used are peroxidase-conjugated
anti-mouse or anti-rabbit IgGs (Invitrogen). Signal was generated
with ECL Plus (Amersham Biosciences) and exposed to X-ray
ﬁlm (Kodak).
Tandem Afﬁnity Puriﬁcation and FT-MS Analysis
Tandem afﬁnity puriﬁcation (TAP) was performed according to the
protocol for the InterPlay Mammalian TAP System (Stratagene).
Proteins were eluted by incubation in 50 mM NH4HCO3
(pH 8.0) at 95C for 5 min. Subsequent Fourier transform-mass
spectrometry (FT-MS) analysis was performed with a nano-HPLC
Agilent 1100 nanoﬂow system connected to a linear quadrupole
ion trap-Fourier transform mass spectrometer (LTQ-FT, Thermo
Electron). The eluate was applied to 10% SDS-PAGE for the
removal of buffer components from the TAP procedure. Subse-
quently, the band containing the eluted proteins was excised
from the gel, and proteins were in-gel reduced with 10 mM dithio-
treitol and alkylated with 50 mM iodoacetamide before in-gel
digestion with trypsin. Peptides were extracted from the gel and
were puriﬁed and desalted with Stage tips.26 Peptide-identiﬁcation
experiments were performed with a nano-HPLC Agilent 1100
nanoﬂow system connected online to a linear ion trap-Fourier
transform (LTQ-FT) (Thermo Electron). Liquid chromatography
(LC) and MS settings are further explained in Table S1, available
online. Peptides and proteins were identiﬁed with the use of the
Mascot (Matrix Science) algorithm for search of a local version
of the NCBInr database. First-ranked peptides were parsed from
Mascot database search html ﬁles with MSQuant for the genera-
tion of unique ﬁrst-ranked peptide lists.
Gene-Order-Conservation Analysis
To assess the gene-order conservation among bacteria, we used
STRING27 in the ‘‘protein mode,’’ using as query the most similar
bacterial protein to NDUFAF3: protein amb2521, from the alpha-
proteobacterium Magnetospirillum magneticum.
Results
Clinical and Enzymatic Data
We identiﬁed ﬁve patients from three families that pre-
sented with a severe metabolic disorder. Shortly after birth,
all affected children from family I presented with lactic, 2009
acidemia.Besides the children’s increasedmuscle tone,phys-
ical examination and radiological and electrophysiological
studies were normal. Patient II-1 showed macrocephaly
and severe muscle weakness and hypotonia as the most
prominent clinical ﬁndings. Patient III-1 developed diffuse
leukomalacia. Despite various interventions and supple-
mentation, all patients deteriorated and died at 2–6 months
of age. Enzymatic analysis ofOXPHOS function in ﬁbroblast
andmuscle revealed a severe isolated complex I deﬁciency in
all investigated patients (Table 1 and Tables S2–S4).
Genetic Analysis and Modeling of NDUFAF3
and the G77R and R122P Substitutions
Multiple genomic stretches of successive homozygous
SNPs, longer than 4 Mb, were present in the DNA of the
patients from families 1 and 2. One of the regions shared
in the patients of family 1 spanned 33.83 Mb (24.23–
58.06 Mb, rs10510540– rs6445945) on chromosome 3.
Patient II-1 of family 2 also had a large homozygous region
on chromosome 3, spanning 26.6 Mb (45.9872.59 Mb,
rs3796376–rs11128275). The SNP haplotype was different
for each family, excluding a common founder mutation.
The genomic sequence of the four coding exons of
NDUFAF3 was determined. The three patients of family 1
were homozygous for c.229 G/C resulting in G77R, the
parents and the second twin were heterozygous for the
mutation, and the older healthy daughter was normally
homozygous. Patient II-1 was homozygous for c.365 G/C
resulting in R122P. His parents and two siblings were
heterozygous for the mutation, and two other siblings
were normally homozygous. Patient III-1 was compound
heterozygous for two mutations: c.2 T/C resulting in
M1T and c.365 G/C resulting in R122P. Three healthy
children in the same family were heterozygous for the
c.365 G/C mutation. Each of the described mutations
was absent in at least 210 ethnic control alleles. The M1T
substitution disrupts the start codon. An overview of the
c.229 G/C and c.365 G/C mutations and evolutionary
conservation of the substituted amino acids is shown in
Figures 1A and 1B, respectively.
A three-dimensional model of NDUFAF3 was made for
a better understanding of the structural consequences of
Table 1. Complex I Activities in Patient Fibroblast and
Muscle Mitochondria
Patient Base Change Amino Acid Change Fibroblasta Musclea
Control - - 217 241
I-1 c.229 G/C G77R n.d.b 23 (32%)
I-2 c.229 G/C G77R 16 (39%) 49 (40%)
I-3 c.229 G/C G77R n.d.b n.d.b
II-1 c.365 G/C R122P 5 (18%) 60 (26%)
III-1 c.2 T/C;
c.365 G/C
M1T; R122P 9 (33%) n.d.b
a NADH:ubiquinone oxidoreducatase activity in nmol/min/mg (percentage
of control, normalized to citrate synthase).
b Not determined.The Amthemutations.ABLASTsearchwith theNDUFAF3 sequence
against all proteins in the PDB resulted in a protein with
unknown function (PDB code 2FVT) that shares 30%
sequence identity over a stretch of 129 amino acids. This
was used as a template for modeling of the NDUFAF3
protein (Figure 1C, positions of the mutations indicated).
The R122P mutation is located at the C-terminal side of
the protein and is predicted to change the local structure
of the loop, which might inﬂuence interactions or the
stability of the protein. Gly77 is conserved between the
2FVT template and the NDUFAF3 model and has back-
bone-torsion angles that are very unfavorable for other
residue types (Figure S2). The G77R mutation is therefore
energeticallyunfavorable and likely todisrupt the structure.
Themodel of theNDUFAF3 structure exposes a large hydro-
phobicdomainof about 600 squared A˚ngstrøms (Figure S3),
which is commonly observed for protein-protein interac-
tions.28,29 The homology model and all modeling details
are available online.
Requirement of NDUFAF3 for Complex I Assembly
and Activity
The speciﬁc complex I deﬁciency was conﬁrmed by SDS-
and BN-PAGE analysis for patient II-1 and patient I-2 ﬁbro-
blasts (Figures 2A and 2B). Protein levels of subunits
NDUFS3 and NDUFA9 were decreased (Figure 2A), and
the amount and in-gel activity of complex I were severely
impaired (Figure 2B, CI WB and CI IGA).
The ﬁbroblast cell lines were complemented with the use
of a NDUFAF3-GFP-expressing baculovirus system. Fig-
ure 2A shows that the GFP-tagged COX8 leader (negative
control) and NDUFAF3 proteins were present after infec-
tion and that the NDUFA9 protein level appears slightly
increased after infection with NDUFAF3-GFP. BN analysis
in Figure 2B shows the restoration of complex I amount
and activity, which could be conﬁrmed by enzymatic assay
(Figure 2C and Table S2). Two-dimensional BN- and SDS-
PAGE immunodetection (Figure 2D) reveals no accumula-
tion of assembly intermediates for patient II-1 as assayed
for peripheral (NDUFS2)- and membrane (ND1)-arm
subunits of complex I. NDUFAF3-GFP baculovirus infec-
tion of a patient ﬁbroblast cell line harboring the NDUFS7
(MIM 601825) V122Mmutation30 did not restore complex
I amount and in-gel activity, further supporting the speci-
ﬁcity of the NDUFAF3 complementation (Figure S1).
To verify the requirement of NDUFAF3 for complex I
assembly, we performed RNA interference in HeLa cells,
using two targets (Figure 2E). In addition to the expected
decrease of NDUFAF3 (Figure 2E) and complex I amount
and activity (Figure 2F) observed, we observed a strong
reduction of the NDUFAF4 protein (Figure 2E). NDUFAF4
(C6ORF66) is a previously described complex I assembly
protein.12To investigateaputative interdependence,weper-
formed RNA interference for NDUFAF4, which also resulted
in decrease in NDUFAF3 protein (Figure 2E) and complex I
amount and activity (Figure 2F). As controls, complexes II
and III remained unaffected by both knockdowns.erican Journal of Human Genetics 84, 718–727, June 12, 2009 721
Figure 1. Genetic and Molecular Characterization of the c.229G/C and c.365 G/C Mutations
(A) DNA samples of (a) a patient from family 1, the c.229 G/C mutation indicated by an arrow, (b) an obligate heterozygote from family 1,
(c) a control, (d) a patient from family 2, the c.365 G/C mutation indicated by an arrow, (e) an obligate heterozygote from family 2, and
(f) a control.
(B) Conservation of the altered amino acids is shown via clustalW alignments. Asterisks (*) indicate identical amino acids, colons (:) indi-
cate conserved substitutions, and periods (.) indicate semiconserved substitutions.
(C) Model of NDUFAF3 and the two mutations found in the patients. Middle panel: NDUFAF3 is shown in ribbon visualization and colored by
secondary structure element (red¼ beta strand, blue¼ alpha helix, green¼ turn, cyan¼ coil). The positions of the two mutations found
in patients are indicated by the arrows and colored yellow. Side panels: the R122P and G77R mutations shown in more detail. The protein is
gray. The side chains of both the wild-type residue (green) and the mutant residue (red) are shown. Both mutations result in modifications
at the same side of the protein.Mitochondrial Localization and Associations
The humanNDUFAF3 gene encodes two isoforms, A and B,
which share a ‘‘domain of unknown function’’ (DUF498).
In addition, the longer A isoform harbors an in silico pre-
dicted N-terminal mitochondrial-targeting sequence of
about 35 amino acids (MitoprotII, TargetP, and Predotar).
Sequence data of the human NDUFAF3 variants and inter-722 The American Journal of Human Genetics 84, 718–727, June 12species homology of the A isoform are summarized in
Table S5. To verify the predicted mitochondrial targeting
of isoform A, we performed confocal microscopy for ana-
lysis of GFP-tagged NDUFAF3 isoform A (Figure 3A) and
subcellular fractionation experiments for analysis of the
wild-type protein (Figure 3B). Both analyses demonstrate
that NDUFAF3 is predominantly (if not exclusively), 2009
Figure 2. Complementation of the Complex I Deficiency in Fibroblasts from Patients I-2 and II-1
NI: not infected. Cox8: infected with GFP-tagged COX8 leader sequence. AF3: NDUFAF3-GFP infected.
(A) SDS-PAGE immunodetections of GFP, NDUFS3, and NDUFA9.
(B) Complex I in-gel activity (CI IGA) and BN-PAGE immunodetections of complex I (ND1), complex V (ATPase a), complex III (core II),
complex IV (COX5A), and complex II (SDHA).
(C) Enzymatic activities of complexes I (assayed as NADH-ubiquinone reductase), II, and IV after normalization to citrate synthase
activity and untreated control (source data in Table S2).
(D) Two-dimensional BN-SDS immunodetections of NDUFS2 and ND1 in control and patient II-1 fibroblasts, before and after complemen-
tation (Compl.).
(E and F) RNA interference-mediated knockdowns of NDUFAF3 and NDUFAF4 in HeLa cells. N: not treated. M: mock transfected. #1, #2:
targets 1 and 2. (E) SDS-PAGE immunodetection of NDUFAF3, NDUFAF4, complex I subunits NDUFS3 and ND1, and control CII-70 kDa, after
each knockdown.
(F) BN-PAGE analysis of complex I in-gel activity (IGA) and immunodetection of complex I subunit NDUFA9, complex II-70 kDa, and
complex III core II subunits.localized to the mitochondrion. In the submitochondrial
fractionation (Figure 3B), NDUFAF3 remained in the pellet
after carbonate extraction. This suggests a strong interac-
tion with the mitochondrial membrane, although this
protein has no predicted transmembrane helices. The
localization appeared identical to that of the NDUFAF4
protein. As controls, integral membrane protein ND1The Amalso remained in the pellet, whereas cytochrome c and
complex I subunit NDUFS3 did not. MtHSP70 and
NDUFS2 display partial membrane association.
The NDUFAF3 protein accurately comigrates with previ-
ously described complex I assembly intermediates 3, 4, and
5.8 (Figure 3C for NDUFAF3-GFP, Figure 3D for endogenous
NDUFAF3). In addition, multiple bands are observed at theerican Journal of Human Genetics 84, 718–727, June 12, 2009 723
Figure 3. Mitochondrial Localization and High-Molecular-Weight Associations of NDUFAF3
(A) NDUFAF3-GFP, mitotracker, and Hoechst staining of NDUFAF3-GFP-inducible HEK293 Flp-in cells at different magnifications (a and b).
(B) SDS-PAGE immunodetection analysis after subcellular and mitochondrial fractionation of HEK293 cells. Cyto: cytoplasm. Mito: mito-
chondria. After sonication of purified mitochondria, the pellet (P) contains membrane structures and the supernatant (S) represents the
soluble fraction. Carbonate extraction unfolds membrane structures, releasing peripherally associated proteins to the supernatant.
(C) Detection of NDUFS3-GFP (S3-GFP) and NDUFAF3-GFP (AF3-GFP) in native protein complexes via fluorscan of a 5%–15% BN-PAGE gel.
Previously identified complex I intermediates are indicated as by Vogel et al.8
(D) Two-dimensional BN- and SDS-PAGE immunodetection of NDUFAF3 and complex I subunits NDUFS2, NDUFS3, and ND1.
(E) TAP identification of binding partners of NDUFAF3. SDS-PAGE immunodetections of proteins after NDUFS3-, NDUFAF3-, and NDUFAF4-
TAP purifications indicated on the left. L: lysate. E: eluate. ‘‘-‘‘: without doxycycline. ‘‘þ’’: with 1 mg/ml doxycycline for 24 hr.approximate size of intermediate 6 (Figure 3C). The same
comigration is observed for NDUFAF4 (Figure 4C). To
investigate putative interactions between NDUFAF3 and
NDUFAF4, we constructed stable HEK293 Trex Flp-in
clones containing TAP-tagged NDUFS3-, NDUFAF3-, and
NDUFAF4-inducible constructs. Each protein was puriﬁed
after 24 hr of expression. TAP of NDUFS3, NDUFAF3, and
NDUFAF4 resulted in copuriﬁcation of all three proteins,
plus NDUFS2 (Figure 3E). Subunits NDUFA9, ND1, and
NDUFA2 were not detected in the eluates, suggesting
that NDUFAF3 and NDUFAF4 predominantly interact
with complex I core subunits NDUFS2 and NDUFS3. To
detect additional proteins, we analyzed the eluates by724 The American Journal of Human Genetics 84, 718–727, June 12mass spectrometry (Table S6). In addition to the copuri-
ﬁcation observed for NDUFS2, NDUFS3, NDUFAF3, and
NDUFAF4, this analysis revealed the copuriﬁcation of
NDUFA5 and NDUFS8.
Role of NDUFAF3 in Complex I Assembly
Inhibition of mitochondrial translation disturbs complex I
assembly because the mitochondrial DNA-encoded ND
subunits of complex I are no longer formed and incorpo-
rated. Such inhibition can be achieved by culturing cells
in the presence of chloramphenicol for>24 hr, which typi-
cally results in accumulation of NDUFS3-containing
assembly intermediates 2 and 3 (see Vogel et al.8 and, 2009
Figure 4. Inhibition of Translation and
Proposed Role of NDUFAF3 during
Complex I Assembly
HEK293 cells were induced for NDUFS3-,
NDUFAF3-, and NDUFAF4-GFP expression
with and without prior chloramphenicol
treatment (5 CAP) for 3 days.
(A) Complex I in-gel activity (CI-IGA)
assay.
(B) SDS-PAGE fluorscan for GFP-tagged
protein.
(C) BN-PAGE immunodetection with anti-
body to GFP. Previously described NDUFS3-
containing intermediates are indicated on
the left as by Vogel et al.8 M: monomer.
Accumulation is indicated with arrows,
referring to subcomplexes of NDUFAF3
(AF3) and of NDUFAF4 (AF4).
(D) The conserved gene cluster in alpha-
proteobacteria that links orthologs of
NDUFAF3 to the bacterial preprotein trans-
locase complex SecD/SecF/YajC, involved
in targeting proteins to the membrane,
and to CrtB, a phytoene/squalene synthe-
tase of which the human ortholog
C8ORF38 has been implicated in complex I
assembly.13 Green: proteins only observed
in bacteria. Red: proteins observed in
eukaryotes and bacteria.
(E) Tentative model for the role of NDUFAF3
and NDUFAF4 during early complex I assembly. Subcomplex 2 is loosely associated to the mitochondrial inner membrane, as demonstrated
by Dieteren et al.,33 by an unknown factor (X). NDUFAF3 and NDUFAF4 are codependent, membrane localized, and present in subcomplex 3,
which contains at least subunits NDUFS2 and NDUFS3, and possibly NDUFS8 and NDUFA5. This complex requires mitochondrial translation
for progression to higher-molecular-weight subcomplexes. Without mitochondrial translation, NDUFAF3 no longer associates with subcom-
plex 3 and the complex, with NDUFAF4, accumulates. Withmitochondrial translation, both proteins are present until subcomplex 6, close to
finalization of holo-complex I. It is yet unknown which factors aid membrane insertion of mitochondrial translation products (indicated
with Y). AF3: NDUFAF3. AF4: NDUFAF4. S3: subcomplex 3. X and Y: unknown factors. ND: ND subunits. Green structure: mitochondrial ribo-
some.Figure 4C, NDUFS3-GFP þ CAP). Given the tight relation
among NDUFS3, NDUFAF3, and NDUFAF4, the effect of
such inhibition on the incorporation of GFP-tagged
NDUFAF3 and NDUFAF4 was investigated. Upon inhibi-
tion, complex I in-gel activity was decreased (Figure 4A),
whereas the amount of GFP-tagged NDUFAF3 and
NDUFAF4 protein remained similar (Figure 4B). Neverthe-
less, inhibition resulted in disturbed incorporation of
NDUFAF3 (Figure 4C) and in accumulation of NDUFAF4
in a complex similar to subcomplex 3 (Figure 4C, arrow).
To obtain additional clues about the function of
NDUFAF3, we performed gene-order-conservation anal-
ysis. Complex I has been lost six times in the evolution
of the currently sequenced eukaryotic genomes.17 Proﬁle-
based homology searches with PSI-Blast conﬁrm the obser-
vation that NDUFAF3 has also been lost from these line-
ages13 and is present in the complex I-containing lineages,
supporting an interaction with complex I. We examined
whether the bacterial orthologs of NDUFAF3 show gene-
order conservation in the alpha-proteobacterial ancestors
of the mitochondria, a reliable indicator of proteinThe Aminteraction.31We detected signiﬁcant gene-order conserva-
tion with the Squalene/phytoene synthase (CrtB) ortholog
(COG1562, C8ORF38) (Figure 4D) that has been implicated
in complex I assembly in man,13 supporting the role for
NDUFAF3 in complex I assembly. Furthermore, we de-
tected signiﬁcant gene-order conservation with the SecF/
SecD/YajC gene cluster. The gene cluster of NDUFAF3
with SecD/SecF/YajC is conserved among 20 genera in the
current version of STRING. In bacteria, proteins of this
cluster are located in the inner membrane, where they
are involved in membrane-protein insertion and interact
with YidC,32 the bacterial ancestor of the mitochondrial
membrane protein OXA1. The link with CrtB is a bit less
conserved, occurring in 13 genera, but still signiﬁcant
(likelihood of interaction SecD – NDUFAF3 ¼ 0.8, likeli-
hood of interaction CrtB – NDUFAF3 ¼ 0.5).
Discussion
We describe ﬁve patients with a severe complex I deﬁ-
ciency presenting with lactic acidemia soon after birth.erican Journal of Human Genetics 84, 718–727, June 12, 2009 725
All children died before the age of six months. The deﬁ-
ciencies were caused by three different mutations in the
NDUFAF3 gene. We show that NDUFAF3 is essential for
human complex I assembly, in line with its predicted
function based on correlated genomic occurrence with
complex I proteins.13
WithNDUFAF3, the sixth assembly protein implicated in
complex I deﬁciency,10–14 we show cooperation ofmultiple
assembly chaperones in similar assembly stepsof complex I.
The interaction among NDUFAF3, NDUFAF4, NDUFS2,
NDUFS3, and, most likely, subunits NDUFS8 and NDUFA5
shows that NDUFAF3 and NDUFAF4 are bound to similar
complex I substructures. In addition, NDUFAF3 and
NDUFAF4colocalize in themitochondrial innermembrane,
comigrate in at least three previously described assembly
intermediates, and are codependent, as shown by RNA
interference. Taken altogether, these data show that
NDUFAF3 andNDUFAF4 cooperate from early to late stages
of complex I assembly in associationwith at least thehighly
conserved subunits NDUFS2, NDUFS3, and NDUFS8, and
accessory subunit NDUFA5 until step 6 in our assembly
scheme.8
The NDUFAF3-NDUFAF4 interaction provides insights
into the mechanism of early complex I assembly. The
requirement of mitochondrial translation for NDUFAF3
to occur in high-molecular-weight associations supports
a function related to mitochondrial translation or steps
thereafter, such as early assembly of the mitochondrial
DNA-encoded ND subunits of complex I. In contrast, the
same inhibition causes NDUFAF4 to accumulate in a small
nuclear-DNA-encoded intermediate similar to that obser-
ved for NDUFS3.8 One explanation for the combined
results is that NDUFAF4, bound to NDUFAF3, recruits
a nuclear-DNA-encoded early assembly intermediate that
contains at least NDUFS2 and NDUFS3 at the mitochon-
drial inner membrane (Figure 4E). Without mitochondrial
translation, NDUFAF3 can no longer efﬁciently associate to
subcomplex 3, and an intermediate that consists of
NDUFAF4 and at least NDUFS2 and NDUFS3 accumulates.
The predicted interaction of the ancestors of NDUFAF3
with the Sec membrane-translocation machinery in
alpha-proteobacteria is exciting, because a Sec-like translo-
case has not yet been demonstrated for the mammalian
OXPHOS system. It supports a role for NDUFAF3 in
coupling mitochondrial translation to membrane inser-
tion during assembly. In addition, the gene-order-conser-
vation analysis links NDUFAF3 to C8ORF38, another
assembly chaperone implicated in complex I deﬁciency.13
In conclusion, we show that mutations in NDUFAF3
cause complex I deﬁciency. Furthermore, characterization
of NDUFAF3 demonstrates its role as a NDUFAF4-interact-
ing complex I assembly protein and highlights a transla-
tion-dependent early assembly mechanism. Discovery of
the involvement of multiple, disease-implicated chaper-
ones in similar assembly stages constitutes an important
step forward in the understanding of the molecular basis
of complex I assembly defects.726 The American Journal of Human Genetics 84, 718–727, June 12,Supplemental Data
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